These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. Das MK; Zipes DP J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177 [TBL] [Abstract][Full Text] [Related]
30. Ventricular tachycardia and sudden cardiac death. Reddy PC; Tandon N; Stafford PR J La State Med Soc; 1999 May; 151(5):281-7. PubMed ID: 10363484 [TBL] [Abstract][Full Text] [Related]
31. [Antiarrhythmic agents in the prevention of sudden cardiac death]. Halawa B Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592 [TBL] [Abstract][Full Text] [Related]
32. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis]. Milberg P; Pott C; Eckardt L; Breithardt G Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808 [TBL] [Abstract][Full Text] [Related]
33. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356 [TBL] [Abstract][Full Text] [Related]
34. Arrhythmia diagnosis and management throughout life in congenital heart disease. Clark BC; Berul CI Expert Rev Cardiovasc Ther; 2016; 14(3):301-20. PubMed ID: 26642231 [TBL] [Abstract][Full Text] [Related]
35. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [TBL] [Abstract][Full Text] [Related]
36. [Sudden cardiac death: definition, mechanisms and risk factors]. Evéquoz D; Zuber M; Erne P Praxis (Bern 1994); 1996 Feb; 85(7):188-96. PubMed ID: 8701183 [TBL] [Abstract][Full Text] [Related]
37. Ventricular tachycardia and ventricular fibrillation. Srivathsan K; Ng DW; Mookadam F Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116 [TBL] [Abstract][Full Text] [Related]
38. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT). Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias. Kuck KH; Siebels J; Schneider MA Herz; 1995 Jun; 20(3):213-8. PubMed ID: 7635402 [TBL] [Abstract][Full Text] [Related]
40. Remodeled left ventricular myocardium remote to infarction sites is the arrhythmogenic substrate for sudden cardiac death. Tsai CF; Ueng KC; Wu DJ; Tsai TP; Lin CS Med Hypotheses; 2010 Oct; 75(4):368-71. PubMed ID: 20399566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]